G0 Phase

Download PDF

Recent Publications on G0 Phase:
Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2. TRF2 is a component of shelterin, the telomere-specific protein complex...	1st July, 2008	Laboratory for Cell Biology and Genetics, The Rockefeller University, New	Genes Dev. 2008 May 1;22(9):1221-30. DOI Direct Link
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation. Sorafenib, a novel drug for metastatic renal cancer, has broad-spectrum...	27th June, 2008	State Key Laboratory of Pharmaceutical Biotechnology, School of Life	Leukemia. 2008 Jun;22(6):1226-33. Epub 2008 Mar 13. DOI Direct Link
Gypenosides induced G0/G1 arrest via inhibition of cyclin E and induction of apoptosis via activation of caspases-3 and -9 in human lung cancer A-549 cells. Gynostemma pentaphyllum Makino is known in Asia for its effect on the...	21st June, 2008	Department of Clinical Pathology, Cheng Hsin Rehabilitation Medical	In Vivo. 2008 Mar-Apr;22(2):215-21.
Effect of survivin regulation of transcription level by p21(waf1) overexpression in HepG2 hepatocellular carcinoma cells. The effect of cyclin-dependent kinase inhibitors Cip1/Waf1 (p21) on...	20th June, 2008	Department of Clinical Laboratory, Union Hospital, Tongji Medical College,	J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):308-13. Epub 2008 DOI Direct Link
Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Chronic myelogenous leukemia (CML) is a myeloproliferative disease...	20th June, 2008	Crystallography and Molecular Biology Division, Saha Institute of Nuclear	Cancer Sci. 2008 Jun;99(6):1109-16. Epub 2008 Apr 21. DOI Direct Link
→View more research publications.

BioNews Results for G0 Phase:
Sensitivity test to predict efficacy of anti-cancer therapies	PharmCast:  Apr 29 2008 8:18PM Matching: g0 phase
Tumor-specific vector for gene therapy	PharmCast:  Apr 15 2008 3:56AM Matching: g0 phase

G0 Phase Patents:
US Patent No.	Title
6525243	Unactivated oocytes as cytoplast recipients of quiescent cell nuclei while maintaining correct ploidy
6884624	Method for measuring the rate of cell reproduction by analysis of nanoliter cell samples
6887711	Method of characterization of biological entities
6894153	Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells
6897054	Human H37 proteins and cDNA encoding the same
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for G0 Phase scientists - we have details of around 152 individuals working on G0 Phase .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.